Skip to content

Establishment of Reference Ranges for Pupil Parameters and Characterization of Age-Related Changes in Healthy Chinese Adults: A Multicenter Cross-Sectional Study

Establishment of Reference Ranges for Pupil Parameters and Characterization of Age-Related Changes in Healthy Chinese Adults: A Multicenter Cross-Sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600130362
Enrollment
Unknown
Registered
2026-08-19
Start date
2026-08-20
Completion date
Unknown
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Chinese adults

Interventions

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years, with no restriction on sex; 2.Best corrected visual acuity (BCVA) >= 0.5, normal intraocular pressure, and no active ocular diseases that may affect pupillary function or measurement results (such as glaucoma or iridocyclitis) detected by slit-lamp examination; 3.No history of systemic diseases that may affect autonomic nervous function or pupillary reflexes, such as diabetes mellitus, Parkinson’s disease, or Horner syndrome; 4.No recent use of medications (such as mydriatic agents, miotic agents, antidepressants, or antihistamines), cosmetics, or health supplements that may influence pupil size or dynamic pupillary responses; 5.Participants are able to understand and comply with all study procedures and voluntarily provide written informed consent;

Exclusion criteria

Exclusion criteria: 1.History of ocular surgery or significant ocular trauma, or presence of organic ocular diseases that may affect pupillary function, including glaucoma, uveitis, iris disorders, mature cataract, severe corneal diseases, or optic nerve diseases; 2.Neurological disorders that may affect pupillary reflexes, including Horner syndrome, oculomotor nerve palsy, Parkinson’s disease, and multiple sclerosis; 3.Systemic diseases associated with significant autonomic neuropathy; 4.Use of medications, cosmetics, or health supplements that may affect pupillary function within 1 week before the examination, including atropine, pilocarpine, antihistamines, antidepressants, sedative-hypnotic agents, and other related agents; 5.Other conditions considered inappropriate for participation by the investigators;

Design outcomes

Primary

MeasureTime frame
Dynamic pupil parameters: constriction latency, constriction amplitude, constriction duration, average constriction velocity, dilation duration, and average dilation velocity;Static pupil parameters: scotopic pupil diameter (SPD), mesopic pupil diameter (MPD), and photopic pupil diameter (PPD);

Countries

China

Contacts

Public ContactZhiqing Li

Tianjin Medical University Eye Hospital

drzhiqing_li@163.com+86 22 86428886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026